Co Diagnostics (Germany) Alpha and Beta Analysis

C97 Stock  EUR 5.16  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Co Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Co Diagnostics over a specified time horizon. Remember, high Co Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Co Diagnostics' market risk premium analysis include:
Beta
(0.70)
Alpha
2.14
Risk
38.47
Sharpe Ratio
0.0572
Expected Return
2.2
Please note that although Co Diagnostics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Co Diagnostics did 2.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Co Diagnostics stock's relative risk over its benchmark. Co Diagnostics has a beta of 0.70  . As returns on the market increase, returns on owning Co Diagnostics are expected to decrease at a much lower rate. During the bear market, Co Diagnostics is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Co Diagnostics Backtesting, Co Diagnostics Valuation, Co Diagnostics Correlation, Co Diagnostics Hype Analysis, Co Diagnostics Volatility, Co Diagnostics History and analyze Co Diagnostics Performance.
For more detail on how to invest in C97 Stock please use our How to Invest in Co Diagnostics guide.

Co Diagnostics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Co Diagnostics market risk premium is the additional return an investor will receive from holding Co Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Co Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Co Diagnostics' performance over market.
α2.14   β-0.7

Co Diagnostics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Co Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Co Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Co Diagnostics Market Price Analysis

Market price analysis indicators help investors to evaluate how Co Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Co Diagnostics shares will generate the highest return on investment. By understating and applying Co Diagnostics stock market price indicators, traders can identify Co Diagnostics position entry and exit signals to maximize returns.

Co Diagnostics Return and Market Media

The median price of Co Diagnostics for the period between Wed, Oct 15, 2025 and Tue, Jan 13, 2026 is 8.64 with a coefficient of variation of 38.19. The daily time series for the period is distributed with a sample standard deviation of 3.36, arithmetic mean of 8.79, and mean deviation of 1.7. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Co Diagnostics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including C97 or other stocks. Alpha measures the amount that position in Co Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Co Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Co Diagnostics' short interest history, or implied volatility extrapolated from Co Diagnostics options trading.

Build Portfolio with Co Diagnostics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in C97 Stock

When determining whether Co Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Co Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Co Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Co Diagnostics Stock:
Check out Co Diagnostics Backtesting, Co Diagnostics Valuation, Co Diagnostics Correlation, Co Diagnostics Hype Analysis, Co Diagnostics Volatility, Co Diagnostics History and analyze Co Diagnostics Performance.
For more detail on how to invest in C97 Stock please use our How to Invest in Co Diagnostics guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Co Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Co Diagnostics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Co Diagnostics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...